Bibliografia Sugerida

Angelucci E. Hematopoietic stem cell transplantation in thalassemia. Hematology Am Soc Hematol Educ

Program. 2010; 2010: 456-62.

Annibale B, Capurso G, Chistolini A, et al. Gastrointestinal causes of refractory iron de ciency anemia in

patients without gastrointestinal symptoms. Am J Med. 2001 Oct 15; 111(6):439-45.

Appelbaum FR. Allogeneic hematopoietic cell transplantation for acute myeloid leukemia when a

matched related donor is not available. Hematology Am Soc Hematol Educ Program. 2008: 412-

7.

Appelbaum FR. Optimising the conditioning regimen for acute myeloid leukaemia. Best Pract Res Clin

Haematol. 2009, 22(4): 543-50.

Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin’s lymphomas: Clinical

features of the major histologic subtypes. Non-Hodgkin’s Lymphoma Classi cation Project. J Clin

Oncol. 1998; 16:2780-95.

Armstrong SA, Look AT. Molecular genetics of acute lymphoblastic leukemia. J Clin Oncol. 2005;

23(26):6306-15.

Attal M, Harousseau JL, Facon T, et al. Single versus double autologous stem cell transplantation for

multiple myeloma. N Engl J Med. 2003; 349:2495-03.

AU Risdall R, Hoppe RT, Warnke R. Non-Hodgkin’s lymphoma: A study of the evolution of the disease

based upon 92 autopsied cases. Cancer. 1979; 44(2):529.

Bain BJ. Diagnosis from the blood smear. N Engl J Med. 2005; 353(5):498-507.

Bandeira DMA, Melo MC, Freire CJ, Chee HC. Análise do per l epidemiológico dos pacientes com

leucemia mielóide crônica do hospital universitário Prof. Alberto Antunes no período de 1996 a

2005. Rev Bras Hematol Hemoter. 2006; 28(Supl 2):Abstr 442.

Barlogie B, Smallwood L, Smith T, Alexanian R. High serum levels of lactic dehydrogenase identify a

high grade lymphoma like myeloma. Ann Intern Med. 1989; 110:521-25.

Baronciani D, Elauroci N, Dini G, Peters C. Spreading and outcome of hemopietic stem cell

transplantation in beta thalassemia major. Data from EBMT registry. Bone Marrow Transplant.

2011; 46:S67.

Bassan R, Gatta G, Tondini C, Willemze R. Adult acute lymphoblastic leukaemia. Crit Rev Oncol Hematol.

2004; 50(3):223-61.

Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. Proposals for the

classi cation of the acute leukaemias. French-American-British (FAB) co-operative group. Br J

Haematol. 1976; 33(4):451-8.

Bennett M. Vitamin B12 de ciency, infertility and recurrent fetal loss. J Reprod Med. 2001 Mar;

46(3):209-12.

Beutler E. Discrepancies between genotype and phenotype in hematolgy: An important frontier. Blood.

2001; 98:2597-602.

Bortolheiro TC. Avaliação de fatores prognósticos e das respostas hematológica, citogenética e

molecular em pacientes com leucemia mielóide crônica tratados com mesilato de imatinibe.

2007. Tese de mestrado. Faculdade de Ciências Médicas da Santa Casa de São Paulo, São Paulo.

Brasil. Ministério da Saúde. Hemovigilância. Manual Técnico de Hemovigilância – Investigação das

Reações Transfusionais Imediatas e Tardias Não Infecciosas. Brasília (DF): Anvisa; 2007.

Brasil. Ministério da Saúde. Instituto Nacional de Câncer. Estimativa 2006: Incidência de Câncer no Brasil.

Disponível em: www.inca.gov.br/estimativa/2006.

Brasil. Ministério da Saúde. Resolução RDC no 57 – Determina o Regulamento Sanitário para Serviços

que desenvolvem atividades relacionadas ao ciclo produtivo do sangue humano e componentes e

procedimentos transfusionais. Brasília(DF): ANVISA; 2010.

Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Especializada.

Manual de condutas básicas na doença falciforme / Ministério da Saúde, Secretaria de Atenção à

Saúde, Departamento de Atenção Especializada. – Brasília: Editora do Ministério da Saúde, 2006.

56 p. – (Série A. Normas e Manuais Técnicos).

Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Especializada.

Manual de eventos agudos em doença falciforme / Ministério da Saúde, Secretaria de Atenção à

Saúde, Departamento de Atenção Especializada. – Brasília: Editora do Ministério da Saúde, 2009.

50 p. – (Série A. Normas e Manuais Técnicos).

Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Especializada.

Guia para uso de hemocomponentes. Brasília (DF): Ministério da Saúde; 2009.

Brecher ME. Technical manual. 15+ ed. Bethesda, MD: American Association of Blood Banks, 2005.

Brown KE, Tisdale J, Barrett AJ, et al. Hepatitis-associated aplastic anemia. N Engl J Med. 1997;

336:1059.

Bunn HF. Pathogenesis and treatment of sickle cell disease. N Engl J Med. 1997; 337:762.

Campana D, Pui CH. Detection of minimal residual disease in acute leukemia: methodologic advances

and clinical signi cance. Blood. 1995; 85(6):1416-34.

Campos MG, Arantes AM, Oliveira JSR, Chauffaille MLLF. Considerações sobre idade e per l de

apresentação em leucemia mielóide crônica. Rev Bras Hematol Hemoter. 2006; 28(Supl 2):Abstr.

452.

Cançado RD, Lobo C, Friedrich JR. Tratamento da anemia ferropriva com ferro por via oral. Rev Bras

Hematol Hemoter. Jun 2010; 32(suppl 2):114-20.

Cançado RD, Lobo C, Friedrich JR. Tratamento da anemia ferropriva com ferro por via parenteral. Rev

Bras Hematol Hemoter. Jun 2010; 32(suppl 2):121-8.

Capra M, Vilella L, Pereira WV, et al. Estimated number of cases, regional distribution and survival of

patients diagnosed with acute myeloid leukemia between 1996 and 2000 in Rio Grande do Sul,

Brazil. Leuk Lymphoma. 2007; 48(12):2381-6.

Carmel R. How I treat cobalamin (vitamin B12) de ciency. Blood. 2008; 112(6):2214.

Catovsky D, et al. Results from LRF Cll4: A UK multicenter randomized trial. Blood (ASH Annual Meeting

Abstracts). 2005; 106:716.

Center for International Blood and Marrow Transplant Research. Available at:

https://campus.mcw.edu/AngelUploads/Content/

CS_IBMTR2/_assoc/ECCBED0AF0A4492BB667FB6227DC7C0

6/SummarySet06_Pt2_ les/frame.htm.

Conferência de Consenso. Uso de sangue e derivados. ABO RevMed Transf. 2002; 9:33-48.

Cortes J, Kantarjian H. Advanced-phase chronic myeloid leukemia. Semin Hematol. 2003; 40(1):79-86.

Council of Europe and the European Commission. Guide to the preparation, use and quality assurance of

blood components. 13th ed. Strasbourg: Council of Europe Publishing; 2007. Covas DT, Langui DM, Bordin JO. Hemoterapia: Fundamentos e prática. São Paulo: Atheneu; 2007.

Covas DT, Ubiali EMA, Santis GC. Manual de medicina transfusional. São Paulo: Atheneu; 2009.

Criteria for the classi cation of monoclonal gammopathies, multiple myeloma and related disorders: A

report of the International Myeloma Working Group. Br J Haematol. 2003; 121(5):749-57.

Cullis JO. Diagnosis and management of anaemia of chronic disease: Current status. Br J Haematol.

2011; 154:289.

Cunningham MJ, Macklin EA, Neufeld EJ, et al. Complications of beta-thalassemia major in North

America. Blood. 2004; 104: 34.

Dickinson CJ. Does folic acid harm people with vitamin B12 de ciency? QJM. 1995 May; 88(5):357-64.

Diehl V, Brillant C, Engert A, et al. Recent interim analysis of the HD11 trial of the GHSG: Intensi cation

of chemotherapy and reduction of radiation dose in early unfavorable stage Hodgkin’s

lymphoma. Blood. 2005; 106:816a-816a.

Durie BGM, Kyle RA, Belch A, et al. Myeloma management guidelines: a consensus report from the

Scienti c Advisors of the International Myeloma Foundation. The Hematology Journal. 2003;

4:379-98.

Eber SW, Armbrust R, Schröter W. Variable clinical severity of hereditary spherocytosis: relation to

erythrocytic spectrin concentration, osmotic fragility and autohemolysis. J Pediatr. 1990; 117:

409.

Eichhorst BF, Busch R, Hop nger G, Pasold R, Hensel M, Steinbrecher C, et al. German CLL Study Group.

Fludarabine plus cyclophosphamide versus udarabine alone in rst-line therapy of younger

patients with chronic lymphocytic leukemia. Blood. 2006; 107(3):885-91.

Estey E, Dohner H. Acute myeloid leukemia. Lancet. 2006: 368: 1894-907.

Estey E. Acute myeloid leukemia and myelodysplastic syndromes in older patients. JCO 2007. 25:1908-

15.

Faderl S, Thomas DA, O’Brien S, Garcia-Manero G, Kantarjian HM, Giles FJ, et al. Experience with

alemtuzumab plus rituximab in patients with relapsed and refractory lymphoid malignancies.

Blood. 2003; 101(9):3413-5.

Flinn IW, et al. Fludarabine and cyclophosphamide produces a higher response rate and more durable

remissions than udarabine in patients with previously untreated CLL: Intergroup trial E2997.

Blood (ASH Annual Meeting Abstracts). 2004; 104.

Foa R, Vitale A. Towards an integrated classi cation of adult acute lymphoblastic leukemia. Rev Clin Exp

Hematol. 2002; 6(2): 181-99.

Fonseca R, Blood E, Rue M, et al. Clinical and biologic implications of recurrent genomic aberrations in

myeloma. Blood. 2003; 101:4569-75.

Fonseca R. Strategies for risk-adapted therapy in myeloma. Hematology. 2007:304-10.

Freedman AS, Friedberg JW, Aster JC. Classi cation of the hematopoietic neoplasms. Uptodate 2011.

Available at: www.uptodate.com.

Freedman AS, Friedberg JW, Aster JC. Clinical presentation and diagnosis of non-Hodgkin lymphoma.

Uptodate 2011. Available at: www.uptodate.com.

Freedman AS, Friedberg JW, Aster JC. Evaluation, staging, and prognosis of non-Hodgkin lymphoma.

Uptodate2011. Available at: www.uptodate.com.

Funke VAM, Medeiros CR, Lima DH, Setúbal DC, Bitencourt MA, Bon m CM, et al. Therapy of chronic

myeloid leukemia with imatinib mesylate in Brazil: Study of 98 cases. Rev Bras Hematol Hemoter.

2005; 27(3):159-65.

Ganji V, Kafai MR. Hemoglobin and hematocrit values are higher and prevalence of anemia is lower in

the post-folic acid forti cation period than in the pre-folic acid forti cation period in US adults.

Am J Clin Nutr. 2009 Jan; 89(1):363-71.

Gehrs BC, Friedberg RC. Autoimmune hemolytic anemia. Am J Hematol. 2002; 69:258.

Gökbuget N, Hoelzer D. Recent approaches in acute lymphoblastic leukemia in adults. Rev Clin Exp

Hematol. 2002; 6(2):114-41.

Gordon MY, Marley SB, Apperley JF, Marin D, Kaeda J, Szydlo R, et al. Clinical heterogeneity in chronic

myeloid leukemia re eting biological diversity in normal persons. Br J Haematol. 2003; 424-9.

Greipp PR, San Miguel J, Durie BG, et al. International Staging System for multiple myeloma. J Clin

Oncol. 2005: 20:3412-20.

Gribben JG. Stem-cell transplantation in chronic lymphocytic leukaemia. Best Pract Res Clin Haematol.

2007; 20(3):513-27.

Grimwade D, Walker H, Oliver F, et al. The importance of diagnostic cytogenetics on outcome in AML:

Analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult

and Children’s Leukaemia Working Parties. Blood. 1998; 92(7):2322-33.

Grotto HZW. Fisiologia e metabolismo do ferro. Rev Bras Hematol Hemoter. Jun 2010; 32(suppl 2):8-17.

Guralnik JM, Eisenstaedt RS, Ferrucci L, et al. Prevalence of anemia in persons 65 years and older in the

United States: Evidence for a high rate of unexplained anemia. Blood. 2004; 104: 2263.

Harmening DM. Modern blood banking e transfusion practices. 5th ed. Philadelphia: FA Davis; 2005.

Harrison CJ, Foroni L. Cytogenetics and molecular genetics of acute lymphoblastic leukemia. Rev Clin

Exp Hematol. 2002; 6(2):91-113.

Hay SN, Scanga L, Brecher ME. Life, death and the risk of transfusion: A university hospital experience.

Transfusion. 2006; 46(9):1491-3.

Hellman D. Rosenberg’s Cancer: principles and practice of oncology. 8th ed. Philadelphia: Lippincott

Williams & Wilkins, 2008. p. 2099-163.

Hellwig TMC, Nachtigal G, Zago A, Faggion J, Bebber FE, Almeida R, et al. Avaliações de variáveis

sociodemográ cas e clínicas dos pacientes com diagnóstico de leucemia mielóide crônica

atendidos no Serviço de Onco-hematologia do Hospital Escola UFPEL. Rev Bras Hematol Hemoter.

2006; 28(Supl 2):Abstr. 449.

Hess JR. Transfusão sanguínea em situações de emergência. ABO Rev Med Transf. 2009; 40:17-26.

Hjalgrim H, Askling J, Sorensen P, Madsen M, Rosdahl N, Storm HH, et al. Risk of Hodgkin’s disease and

other cancers after infectious mononucleosis. J Natl Cancer Inst. 2000 Sep 20; 92(18):1522-8.

Huang CR, Chang WN, Tsai NW, Lu CH. Serial nerve conduction studies in vitamin B12 de ciency-

associated polyneuropathy. Neurol Sci. 2011 Feb; 32(1):183-6.

Izaks GJ, Westendorp RG, Knook DL. The de nition of anemia in older persons. JAMA. 1999; 281:1714.

Jabbour EJ, et al. Adult acute myeloid leukemia. Mayo Clin Proc. 2006; 81(2):247-60.

Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007; 57(1):43-66.

Jemal A, Thomas A, Murray T, Thun M. Cancer statistics 2002. CA Cancer J Clin. 2002; 52(1):23-47.

King KE, Ness PM. Treatment of autoimmune hemolytic anemia. Semin Hematol. 2005; 42:131.

Küppers R, Rajewsky K, Zhao M, et al. Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from

histological sections show clonal immunoglobulin gene rearrangements and appear to be

derived from B cells at various stages of development. Proc Natl Acad Sci USA. 1994; 91:10962-6.

Kyle RA. Multiple myeloma: Review of 869 cases. Mayo Clin Proc. 1975; 50:29-40.

Lechner K, Jäger U. How I treat autoimmune hemolytic anemias in adults. Blood. 2010; 116:1831.

Lo-Coco E, et al. The biology of acute promyelocytic leukimia and its impact on diagnosis and treatment.

Hematology. 2006:156-61.

Lorand-Metze I, Pagnano KBB, Vieira VA, Delamain MT, Rossini MS, Metze K. Fatores que in uem na

resposta citogenética com o uso do imatinibe em pacientes com leucemia mielóide crônica. Rev

Bras Hematol Hemoter. 2005; 27(Supl 2):Abstr 365.

Marino PL. Anemia e transfusão de hemácias na UTI. In: Marino PL. Compêndio na UTI. 3ª ed. São Paulo:

Artmed, 2007. p. 541-57.

Marino PL. Reposição de colóides e cristalóides. In: Marino PL. Compêndio na UTI. 3ª ed. São Paulo:

Artmed, 2007. p. 195-202.

Marsh JC, Ball SE, Cavenagh J, et al. Guidelines for the diagnosis and management of aplastic anaemia.

Br J Haematol. 2009; 147:43.

Michel M, Chanet V, Dechartres A, et al. The spectrum of Evans syndrome in adults: new insight into the

disease based on the analysis of 68 cases. Blood. 2009; 114:3167.

Milligan DW, et al. Guidelines on the management of acute myeloid leukaemia in adults. BJH. 2006;

135:450-74.

Mòdol Deltell J, Juncà Piera J, Tudela Hita P, Flores López A. Pernicious anemia: Masking of B12 vitamin

de ciency by folic acid. Med Clin (Barc). 2007 Mar 10; 128(9):359.

Montserrat E. Treatment options in chronic lymphocytic leukemia. Hematol J. 2004; 5(Suppl 1):S2-9.

Moreton P, Kennedy B, Lucas G, Leach M, Rassam SM, Haynes A, et al. Eradication of minimal residual

disease in B-cell chronic lymphocytic leukemia after alemtuzumab therapy is associated with

prolonged survival. J Clin Oncol. 2005; 23(13):2971-9.

Napolitano LM, Kurek S, Luchette FA, Corwin HL, Barie PS, Tisherman SA, et al. Clinical practice

guideline: Red blood cell transfusion in adult trauma and critical care. Crit Care Med. 2009;

37(12):3124-57.

NCCN (National Comprehensive Cancer Network) Clinical Practice Guidelines in Oncology. Multiple

myeloma. 2008; 1. Available at: www.nccn.org.

NCCN Guidelines™ & Clinical Resource. Non-Hodgkin’s Lymphomas. Available at:

www.nccn.org/professionals/physician_gls/pdf/nhl.pdf.

Neves MAS, Delgado RB. Suporte hemoterápico ao paciente em emergência médica. Rev Med Minas

Gerais. 2010; 20(4):568-77.

Olivieri NF. The beta-thalassemias. N Engl J Med. 1999; 341:99.

Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin. 1999; 49:33-64.

Patel KV, Longo DL, Ershler WB, et al. Haemoglobin concentration and the risk of death in older adults:

Differences by race/ethnicity in the NHANES III follow-up. Br J Haematol. 2009; 145:514.

Patel KV. Epidemiology of anemia in older adults. Semin Hematol. 2008; 45:210.

Pita MT, Loggetto SR, Carneiro JDA, Garanito MP, Seber A, Maluf EMCP. Anemia aplástica grave:

Tratamento. Projeto Diretrizes. Associação Médica Brasileira, 2008.

Prabhakaran K, Jacobs BL, Smaldone MC, Franks ME. Stuttering priapism associated with hereditary

spherocytosis. Can J Urol. 2007; 14:3702.

Price EA, Mehra R, Holmes TH, Schrier SL. Anemia in older persons: etiology and evaluation. Blood Cells

Mol Dis. 2011; 46:159.

Proietti ABFC, Cioffi JGM, Delgado RB, Carvalho RVF, Givisiez FN. Condutas para a prática clínica,

hemoterapia. Fundação Centro de Hematologia e Hemoterapia de Minas Gerais, 2010.

Pui CH, Relling MV, Downing JR. Acute lymphoblastic leukemia. N Engl J Med. 2004; 350(15):1535-48.

Quinn CT, Rogers ZR, Buchanan GR. Survival of children with sickle cell disease. Blood. 2004; 103:4023.

Rabhi S, Benjelloune H, Meziane M, et al. Hereditary spherocytosis with leg ulcers healing after

splenectomy. South Med J. 2011; 104:150.

Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. Fludarabine compared with

chlorambucil as primary therapy for chronic lymphocytic leukemia. N Engl J Med. 2000;

343(24):1750-7.

Randolph TR. Advances in acute lymphoblastic leukemia. Clin Lab Sci. 2004 Fall; 17(4):235-45.

Randon J, Miraglia del Giudice E, Bozon M, et al. Frequent de novo mutations of the ANK1 gene mimic a

recessive mode of transmission in hereditary spherocytosis: Three new ANK1 variants: ankyrins

Bari, Napoli II and Anzio. Br J Haematol. 1997; 96: 500.

RC Ratton. Emergências médicas e terapia intensiva. 3a ed. Rio de Janeiro: Guanabara Koogan, 2005.

Reece DE. An update of the management of multiple myeloma: The changing landscape. Hematology.

2005; 353-9.

Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010; 376:2018.

Reinstatler L, Qi YP, Williamson RS, Garn JV, Oakley GP Jr. Association of biochemical B12 de ciency with

metformin therapy and vitamin B12 supplements: the National Health and Nutrition

Examination Survey, 1999-2006. Diabetes Care. 2012 Feb; 35(2):327-33.

Rose AH, Kotzé A, Doolan D, Norfolk DR, Bellamy MC. Massive transfusion: Evaluation of current clinical

practice and outcome in two large teaching hospital trusts in Northern England. Vox Sang. 2009;

97(3):247-53.

Rozman C, Marín P, Nomdedeu B, Montserrat E. Criteria for severe aplastic anaemia. Lancet. 1987; 2:955.

Rund D, Rachmilewitz E. Beta-thalassemia. N Engl J Med. 2005; 353:1135.

Sallah S, Wan JY, Hanrahan LR. Future development of lymphoproliferative disorders in patients with

autoimmune hemolytic anemia. Clin Cancer Res. 2001; 7:791.

Sanz MA, et al. A Modi ed AIDA Protocol with anthracycline-based consolidation results in high

antileukemic efficacy and reduced toxicity in newly diagnosed PML/RAR – positive acute

promyelocytic leukemia. Blood. 1999; 94(9):3015-21.

Sanz MA. Treatment of acute promyelocytic leukemia. Hematology. 2006; 147-55.

Sarzynski E, Puttarajappa C, Xie Y, et al. Association between proton pump inhibitor use and anemia: a

retrospective cohort study. Dig Dis Sci. 2011 Aug; 56(8):2349-53.

Schilling RF. Risks and bene ts of splenectomy versus no splenectomy for hereditary spherocytosis: A

personal view. Br J Haematol. 2009; 145:728.

Sharabi A, Cohen E, Sulkes J, Garty M. Replacement therapy for vitamin B12 de ciency: comparison

between the sublingual and oral route. Br J Clin Pharmacol. 2003 Dec; 56(6):635-8.

Slichter SJ. Evidence-Based Platelet Transfusion Guidelines. Hematology. 2007; 172-8. [Cited 2010 June

10]. Available from: http://asheducationbook.hematologylibrary.org /cgi/content/

full/2007/1/172.

Slovak ML, Kopecky KJ, Cassileth PA, et al. Karyotypic analysis predicts outcome of preremission and

postremission therapy in adult acute myeloid leukemia: A Southwest Oncology Group/ Eastern

Cooperative Oncology Group study. Blood. 2000; 96 (13):4075-83.

Smih J, Rahilly M, Davidson K. Extramedullary haematopoiesis secondary to hereditary spherocytosis. Br

J Haematol. 2011; 154:543.

Smith A, Wisloff F, Samson D. Guidelines on the diagnosis and mana gement of multiple myeloma 2005.

Br J Haematol. 2005; 132:410-51.

Smith OP, Hann IM, Chessells JM, et al. Haematological abnormalities in Shwachman-Diamond

syndrome. Br J Haematol. 1996; 94:279.

Spinella PC. Uma abordagem nova e equilibrada à transfusão no choque hemorrágico. ABO Rev Med

Transf. 2009; 40:27-35.

Stabler SP. Vitamin B12 De ciency. N Engl J Med. 2013; 368:149-60.

Stainsby D, MacLennan S, Thomas D, Isaac J, Hamilton PJ. British Committee for Standards in

Haematology. Guidelines on the management of massive blood loss. Br J Haematol. 2006;

135(5):634-41.

Stanworth S, Hyde C, Heddle N, Rebulla P, Brunskill S, Murphy MF. Prophylatic platelet transfusion for

haemorrage after chemotherapy and steem cell transplantation. Cochrane Database of

Sistematic Reviews. The Cochrane Library. CD004269.

Steven L, et al. United States multicenter study of arsenic trioxide in relapse acute promyelocytic

leukemia. J Clin Oncol. 2001; (19): 3852-60.

Szczepiorkowski ZM, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, et al. Guidelines on

the use of therapeutic apheresis in clinical practice – Evidence-based approach from the

apheresis applications committee of the American Society of Apheresis. J Clin Apher. 2007;

22:106-75.

Tefferi A, Dewald GW, Litzow ML, Cortes J, Mauro MJ, Talpaz M, et al. Chronic myeloid leukemia: Current

application of cytogenetics and molecular testing for diagnosis and treatment. Mayo Clin Proc.

2005; 80(3):390-402.

Toh BH, van Driel IR, Gleeson PA. Pernicious Anemia. N Engl J Med. 1997; 337:1441-8.

Traina F. De ciência de ferro no paciente submetido à ressecção gástrica ou intestinal: Prevalência,

causas, repercussões clínicas, abordagem diagnóstica e prevenção. Rev Bras Hematol Hemoter.

Jun 2010; 32(suppl 2):78-83.

Vamvakas EC, Blajchman MA. Transfusion-related mortality: The ongoing risks of allogeneic blood

transfusion and the available strategies for their prevention. Blood. 2009; 113(15):3406-17.

Vitale A, Guarini A, Chiaretti S, Foà R. The changing scene of adult acute lymphoblastic leukemia. Curr

Opin Oncol. 2006; 18(6): 652-9.

Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005; 352:1011.

Wierda W, O’Brien S, Wen S, Faderl S, Garcia-Manero G, Thomas D, et al. Chemoimmunotherapy with

udarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic

leukemia. J Clin Oncol. 2005; 23(18):4070-8.

Young NS. Acquired aplastic anemia. Ann Intern Med. 2002; 136: 534.

Zent CS, Kay NE. Chronic lymphocytic leukemia: Biology and current treatment. Curr Oncol Rep. 2007;

9(5):345-52.

 

OceanofPDF.com